Lithuania vs Slovenia: HICP - Tea, mate and other plant-derived products for infusion (ND)
Lithuania
1.89
in 2026
Slovenia
2.18
in 2026
Lithuania rank
3rd
Slovenia rank
2nd
HICP - Tea, mate and other plant-derived products for infusion (ND) over time
- Lithuania
- Slovenia
How they compare
Slovenia currently reports 2.18 against 1.89 in Lithuania, a difference of 0.29.
That makes Slovenia's figure about 1.2 times Lithuania's.
The two have swapped places 1 time across 27 shared years of data; in 2000 it was Lithuania ahead.
Lithuania ranks 3rd and Slovenia ranks 2nd of 27 countries.
Lithuania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lithuania | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.63 | 1.32 | 1.31 | Lithuania |
| 2010s | 2.15 | 1.04 | 1.11 | Lithuania |
| 2020s | 2.03 | 1.59 | 0.4371 | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hicp - tea, mate and other plant-derived products for infusion (nd), Lithuania or Slovenia?
- Slovenia, at 2.18 against 1.89 in Lithuania as of 2026.
- What is the difference in hicp - tea, mate and other plant-derived products for infusion (nd) between Lithuania and Slovenia?
- 0.29, with Slovenia ahead.
- How many years of comparable data are there for Lithuania and Slovenia?
- 27 years are reported by both, from 2000 to 2026.
- How do Lithuania and Slovenia rank globally for hicp - tea, mate and other plant-derived products for infusion (nd)?
- Lithuania ranks 3rd and Slovenia ranks 2nd of 27 countries.
- Where does this data come from?
- European Central Bank, published as HICP - Tea, mate and other plant-derived products for infusion (ND) (Neither seasonally nor working day adjusted, Sub-index weight). Statizoid refreshes it automatically from the source and publishes the full history for both places.